Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Interviews

Interview: Pascal Vinet, director of global operations for healthcare at Air Liquide

Leading international supplier of healthcare gases and services, Air Liquide has recently expanded its hygiene division to the Asia-Pacific region. We speak to Pascal Vinet, director of global operations for healthcare, about the group’s strategy.

Interview: Dr Peter Cole, managing partner at Lancet Laboratories

South African diagnostic lab group Lancet is consolidating the African lab market, expanding into 12 countries in 12 years. We speak to managing partner, Dr Peter Cole, about the South African healthcare services market generally, the different African markets and the challenge posed by European and Indian competitors.

Interview: Javier Okhuysen, Co-CEO and founder salaUno, Mexico

SalaUno is looking to revolutionise ophthalmology provision in Mexico City with some lessons from India. Okhuysen claims that cataract surgery costs just $390, around a fifth of the cost in the UK. The sector attracts little government support, forcing consumers to turn to traditional high cost providers. We talk to Okhuysen about the new business model. Ophthalmology provision in Mexico falls victim to an on-going systemic problem, with options limited to high cost, low volume private providers. As is the case across the world when it comes government focus, ophthalmology is the ugly cousin of rising lifestyle diseases such as hypertension, obesity, diabetes and cancer.

Interview: Jaime Cervantes Covarrubias, CEO, Grupo VitalMex, Mexico

Persuading public sector hospitals to outsource the management of surgery sounds unlikely to lead to business success. After all, surgeons are powerful and surgery is a jealously guarded core competency. You might imagine that few public sector hospitals would willingly outsource. Yet Vitalmex has grown sales to $300m with this very business model and is now active in Peru, Colombia and Brazil. Thailand and Turkey could be next.

Interview: Dr Nata Menabde, WHO Representative to India

A scheme that gives 37m poor Indians access to acute care for a very low price and engages with the private sector sounds too good to be true. We talk to Dr Menabde about the Rashtriya Swasthya Bima Yojana (RSBY), a nationwide secondary care insurance scheme launched by India in 2008. Has the RSBY been a success? What is its future? And what does it mean for the future of healthcare in India and other Emerging Markets?

Interview: Bruno Marie, CEO, Almaviva Santé

After 20 years in banking, Bruno Marie quit in 2007 to set up Almaviva Santé. The regional chain with seven private hospitals near Marseille is the second largest player in Provence-Alpes-Côte d'Azur (PACA) and in 2014 bought a 250 bed hospital near Paris. The group has particular specialisations in orthopaedics, ophthalmology, cardiology and gastroenterology. Almaviva is backed by investment company Gimv and UI Gestion and currently manages over 750 beds and 65 operating rooms, employing over 1,000 staff and 600 independent physicians.

Interview: Biju Mohandas, head of Health and Education in Africa, IFC

The International Finance Corporation, the investment arm of the World Bank, is one of the biggest investors in private sector healthcare in the Emerging Markets. We spoke to Mohandas about the IFC’s investment strategy in Sub-Saharan Africa (SSA).

Interview: John Coulter, Vice President, Commercial Operations, Europe, Diagnostics, Abbott

Major suppliers enjoy perhaps the clearest view of how the diagnostics lab sector, private and public, is changing. And, as they seek to sell comprehensive and competitive solutions to lab operators, such suppliers are managing changing market dynamics and profitability within the sector.

Interview: Richard Ajayi, CEO Therapia Health

Healthcare service companies in emerging markets can tap into the knowledge and capacity of their opposite numbers in more developed markets. Therapia Health in Nigeria is a great example of this, with links to operators in Austria, Belgium, the UK, South Africa and India. Backed by a $5m investment from Abraaj, London-trained doctor Richard Ajayi has built an IVF clinic and lab chain and is now building a wider services platform.

Investing in Africa’s underdog healthcare businesses

BlueCloud Healthcare, a UK-based investment advisory firm and start-up business incubator focused healthcare service companies in sub-Saharan Africa, is tapping into private equity’s growing interest in the continent. Healthcare Nova spoke to founder Steven Adjei about the company and his take on investing in Africa.

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us